Incidence and risk factors of hepatitis C virus infection in a haemodialysis unit

Nephrology Dialysis Transplantation

Volumn 12, Issue 4, 1997, Pages 736-740

  Forns, Xavier ^a,b   Fernández Llama, Patricia ^a   Pons, Mercé ^a   Costa, Josep ^a   Ampurdanés, Sergi ^a   López Labrador, Francesc Xavier ^a   Olmedo, Eva ^a   López Pedret, José ^a   Darnell, Alejandro ^a   Revert, Lluis ^a   Sánchez Tapias, José María ^a   Rodés, Juan ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Blood transfusion; Genotypes; Haemodialysis; HCV; Nosocomial; Transmission

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; FEMALE; GENOTYPE; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL INFECTION; HUMAN; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROCONVERSION; VIRUS TRANSMISSION;

ADULT; AGED; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK FACTORS;

EID: 8244225178     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/12.4.736     Document Type: Article

References (30)

1. Köhler H. The prevalence of hepatitis C in different countries of the ERA/EDTA area. Nephrol Dial Transplant 1995; 10: 468-469
2. Pol S, Romeo R, Zins B, et al., Hepatitis C virus RNA in anti-HCV positive hemodialysed patients: significance and therapeutic implications. Kidney Int 1993; 44: 1097-1100
3. Morales J, Munoz MA, Castellano G, et al. Impact of hepatitis C in long-functioning renal transplants: a clinico-pathological follow-up. Transplant Proc 1993; 25: 1450-1453
4. Fabrizi F, Lunghi G, Marai P, et al., Virological and histological features of hepatitis C virus (HCV) infection in kidney transplant recipients. Nephrol Dial Transplant 1996; 11: 159-164
5. Chauveau P, Courouce AM, Lemarrec N, et al., Antibodies to hepatitis C virus by second generation test in hemodialysed patients. Kidney Int 1993; 41[Suppl]: S149-S152
6. Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Sem Liver Dis 1995; 15: 41-63
7. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159
8. Garson JA, Ring C, Tuke P, Tedder RS. Enhanced detection by PCR of hepatitis C virus RNA [letter]. Lancet 1990; 336: 878-879
9. Kwok S, Higuchi R. Avoiding false-positives with PCR. Nature 1989; 339: 237-238
10. Davidson F, Simmonds P, Ferguson JC et al. Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5′ non-coding region. J Gen Virol 1995; 76: 1197-1204
11. Di Bisceglie AM, Goodman ZD, Ishak KG, Hoofnagle JH, Melpolder JJ, Alter HJ. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology 1991; 14: 969-974
12. Caramelo C, Ortiz A, Aguilera B et al. Liver disease patterns in hemodialysis patients with antibodies to hepatitis C virus. Am J Kidney Dis 1993; 22: 822-828
13. Niu MT, Coleman PJ, Alter MJ. Multicenter study of hepatitis C virus infection in chronic hemodialysis patients and haemodialysis center staff members. Am J Kidney Dis 1993; 22: 568-573
14. Fabrizi F, Lunghi G, Guarnori I et al. Incidence of seroconversion for hepatitis C virus in chronic haemodialysis patients: a prospective study. Nephrol Dial Transplant 1994; 9: 1611-1615
15. Dentico P, Volpe A, Buongiorno R et al. HCV third generation test in haemodialysis patients. Ital J Gastroenterol 1995; 27: 300-302
16. Courouce AM, Lemarrec N, Girault A, Ducamp S, Simon N. Anti-hepatitis C virus (anti-HCV) seroconversion in patients undergoing haemodialysis: comparison of second and third-generation HCV assays. Transfusion 1994; 34: 790-795
17. Courouce AM, Bouchardeau F, Chauveau P et al. Hepatitis C virus (HCV) infection in haemodialysed patients: HCV-RNA and anti-HCV antibodies (third generation assays). Nephrol Dial Transplant 1995; 10: 234-239
18. Donahue JG, Muñoz A, Ness PM et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992; 327: 369-373
19. Jadoul M, Cornu C, Van Ypersele de Strihou C. Incidence and risk factors for hepatitis C seroconversion in haemodialysis: a prospective study. Kidney Int 1993; 44: 1322-1326
20. Garcia -Valdecasas J, Bernai C, García F, Leyva A, Cerezo S. Epidemiological factors involved in hepatitis C virus infection in patients with renal disease. Nephrol Dial Transplant 1995; 10[Suppl]: 81-82
21. Simon N, Courouce AM, Lemarrec N, Trepo C, Ducamp S. A twelve year natural history of hepatitis C virus infection in haemodialysed patients. Kidney Int 1994; 46: 504-511
22. Zeuzem S, Scheuermann EH, Waschk D, et al. Phylogenetic analysis of hepatitis C virus isolates from haemodialysis patients. Kidney Int 1996; 49: 896-902
23. Sampietro M, Badalamenti S, Salvadori S. High prevalence of a rare hepatitis C virus in patients treated in the same haemodialysis unit: evidence for nosocomial transmission of HCV. Kidney Int 1995; 47: 911-917
24. Stuyver L, Claeys H, Wyseur A et al. Hepatitis C virus in a haemodialysis unit: molecular evidence for nosocomial transmission. Kidney Int 1996; 49: 889-895
25. Allander T, Medin C, Jacobson SH, Grillner L, Persson MA. Hepatitis C transmission in a hemodialysis unit: molecular evidence for spread of virus among patients not sharing equipment. J Med Virol 1994; 43: 415-419
26. Cendoroglo Neto M, Draibe SA, Silva AE, et al., Incidence and risk factors for hepatitis B virus and hepatitis C virus infection among haemodialysis and CAPD patients: evidence for environmental transmission. Nephrol Dial Transplant 1995; 10: 240-246
27. Yuasa T, Ishikawa G, Manabe S, Sekiguchi S, Takeuchi K, Miyamura T. The particle size of hepatitis C virus estimated by filtration through microporous regenerated cellulose fibre. J Gen Virol 1991; 72: 2021-2024
28. Hubmann R, Zazgomik J, Gabriel C, Garbeis B, Blauhut B. Hepatitis C virus-does it penetrate the haemodialysis membrane? PCR analysis of haemodialysis ultrafiltrate and whole blood. Nephrol Dial Transplant 1995; 10: 541-542
29. Caramelo C, Navas S, Alberola ML, Bermejillo T, Reyero A, Carreño V. Evidence against transmission of hepatitis C virus through haemodialysis ultrafiltrate and peritoneal fluid. Nephron 1994; 66: 470-473
30. Niu MT, Alter MJ, Kristensen C, Margolis HS. Outbreak of haemodialysis-associated non-A, non-B hepatitis and correlation with antibody for hepatitis C virus. Am J Kidney Dis 1992; 19: 345-352